• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 4 hours
In the last 6 hours
In the last 8 hours
Earlier today
Yesterday
In the last 7 days
Africa CDC lambasts Moderna for halting Kenyan vaccine plant Research Professional News04:29 18-Apr-24
Coroner probes vaccine link to young woman's death The Canberra Times23:16 16-Apr-24
In the last month
2 Stocks Down 30% to Buy Right Now The Motley Fool06:00 14-Apr-24
1 New Green Flag for Moderna and Merck Stock The Motley Fool08:48 12-Apr-24
Moderna pauses plans to build mRNA facility in Kenya Pharmaceutical Technology06:58 12-Apr-24
Moderna Betrays Africa, Says AHF Business Wire (Press Release)23:25 11-Apr-24
Moderna puts Kenya plant plans on hold AfricaNews10:21 11-Apr-24
Cancer Vaccine Looks Promising Outside the Beltway (Weblog)06:18 11-Apr-24
RTVE Unveils New Fiction Series at Miptv todotvnews.com08:27 8-Apr-24
Moderna Reports Phase I/II Data for Propionic Acidemia mRNA Therapy Genetic Engineering and Biotechnology News21:36 3-Apr-24
Moderna Continues To Build A Pipeline Seeking Alpha13:41 3-Apr-24
Moderna Stock: Buy, Sell, or Hold? The Motley Fool08:47 1-Apr-24
Better Recovery Story Buy: Pfizer vs Moderna The Motley Fool05:12 1-Apr-24
Better Cathie Wood Stock: Moderna vs. Intellia The Motley Fool06:01 28-Mar-24
Blackstone to provide $750m for Moderna’s ‘flu programme Pharmaceutical Technology05:33 28-Mar-24
view more headlines
23 Apr 16:06

About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.